TY - JOUR
T1 - Label-free, multiplexed biomolecular analysis using arrays of silicon photonic microring resonators
AU - Washburn, Adam L.
AU - Luchansky, Matthew S.
AU - McClellan, Melinda S.
AU - Bailey, Ryan C.
N1 - Funding Information:
We acknowledge support from the NIH Director’s New Innovator Award Program, part of the NIH
Funding Information:
Roadmap for Medical Research, through grant number 1-DP2-OD002190-01, and from the Camille and Henry Dreyfus Foundation.
PY - 2011
Y1 - 2011
N2 - We have developed a broadly applicable biosensing platform based upon chip-integrated silicon photonic microcavities. Large arrays of microring resonators are robustly fabricated using standard semiconductor processing methods on silicon-on-insulator wafers. Microring resonators are label-free sensors that support spectrally well-defined optical modes that are extremely sensitive to surface binding-induced changes in the local refractive index. Each microring can be uniquely functionalized with a biomolecularly-specific capture agent (antibody, cDNA, aptamer, etc.) allowing sensitive and multiplexed detection of a range of protein and nucleic acid targets at sub-pM levels and from within complex matrices, such as human serum. This paper describes recent advances in sensor design, characterization, and detection of biomolecules for applications in bioterrorism surveillance and medical diagnostics, with an added emphasis on the incorporation of emerging capture agents that give improved sensor performance.
AB - We have developed a broadly applicable biosensing platform based upon chip-integrated silicon photonic microcavities. Large arrays of microring resonators are robustly fabricated using standard semiconductor processing methods on silicon-on-insulator wafers. Microring resonators are label-free sensors that support spectrally well-defined optical modes that are extremely sensitive to surface binding-induced changes in the local refractive index. Each microring can be uniquely functionalized with a biomolecularly-specific capture agent (antibody, cDNA, aptamer, etc.) allowing sensitive and multiplexed detection of a range of protein and nucleic acid targets at sub-pM levels and from within complex matrices, such as human serum. This paper describes recent advances in sensor design, characterization, and detection of biomolecules for applications in bioterrorism surveillance and medical diagnostics, with an added emphasis on the incorporation of emerging capture agents that give improved sensor performance.
UR - http://www.scopus.com/inward/record.url?scp=84857152358&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84857152358&partnerID=8YFLogxK
U2 - 10.1016/j.proeng.2011.12.016
DO - 10.1016/j.proeng.2011.12.016
M3 - Conference article
AN - SCOPUS:84857152358
SN - 1877-7058
VL - 25
SP - 63
EP - 66
JO - Procedia Engineering
JF - Procedia Engineering
T2 - 25th Eurosensors Conference
Y2 - 4 September 2011 through 7 September 2011
ER -